Susan Brandenburg
Overview
Explore the profile of Susan Brandenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janas A, Jordan J, Bertalan G, Meyer T, Bukatz J, Sack I, et al.
Front Oncol
. 2024 Sep;
14:1402578.
PMID: 39324003
Introduction: Magnetic Resonance Elastography (MRE) allows the non-invasive quantification of tumor biomechanical properties . With increasing incidence of brain metastases, there is a notable absence of appropriate preclinical models to...
2.
Al-Rubaiey S, Senger C, Bukatz J, Krantchev K, Janas A, Eitner C, et al.
Radiother Oncol
. 2024 Jul;
199:110444.
PMID: 39067705
Background: Radionecrosis is a common complication in radiation oncology, while mechanisms and risk factors have yet to be fully explored. We therefore conducted a systematic review to understand the pathogenesis...
3.
Zhang W, Blank A, Kremenetskaia I, Nitzsche A, Acker G, Vajkoczy P, et al.
BMC Cancer
. 2024 Mar;
24(1):369.
PMID: 38519889
CD13 (APN) is an Alanyl-Aminopeptidase with diverse functions. The role of CD13 for gliomas is still unknown. In this study, data of glioma patients obtained by TCGA and CGGA databases...
4.
Bungert A, Urbantat R, Jelgersma C, Bekele B, Mueller S, Mueller A, et al.
Neuropathol Appl Neurobiol
. 2022 Nov;
49(1):e12863.
PMID: 36346010
Aims: Glioblastomas are high-grade brain tumours that are characterised by the accumulation of brain-resident microglia and peripheral macrophages. Recruitment of these myeloid cells can be facilitated by CCR2/CCL2 signalling. Besides...
5.
Urbantat R, Jelgersma C, Vajkoczy P, Brandenburg S, Acker G
Oncol Rep
. 2022 Jul;
48(3).
PMID: 35856448
Standard of care therapy for glioblastoma (GBM) consisting of surgical removal, temozolomide (TMZ) and radiotherapy fails to cure the disease and median survival is limited to 15 months. Therapeutic approaches...
6.
Urbantat R, Jelgersma C, Brandenburg S, Nieminen-Kelha M, Kremenetskaia I, Zollfrank J, et al.
Int J Mol Sci
. 2021 Oct;
22(20).
PMID: 34681839
Tumor recurrence is the main challenge in glioblastoma (GBM) treatment. Gold standard therapy temozolomide (TMZ) is known to induce upregulation of IL8/CXCL2/CXCR2 signaling that promotes tumor progression and angiogenesis. Our...
7.
Jelgersma C, Senger C, Kluge A, Janas A, Nieminen-Kelha M, Kremenetskaia I, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298631
CyberKnife stereotactic radiosurgery (CK-SRS) precisely delivers radiation to intracranial tumors. However, the underlying radiobiological mechanisms at high single doses are not yet fully understood. Here, we established and evaluated the...
8.
Urbantat R, Vajkoczy P, Brandenburg S
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34203660
With a median patient survival of 15 months, glioblastoma (GBM) is still one of the deadliest malign tumors. Despite immense efforts, therapeutic regimens fail to prolong GBM patient overall survival...
9.
Xu R, Teich W, Frenzel F, Hoffmann K, Radke J, Rosler J, et al.
Front Oncol
. 2021 May;
11:654300.
PMID: 34041024
Objective: The utilization of fluorescein-guided biopsies and resection has been recently discussed as a suitable strategy to improve and expedite operative techniques for the resection of central nervous system (CNS)...
10.
Urbantat R, Blank A, Kremenetskaia I, Vajkoczy P, Acker G, Brandenburg S
Int J Mol Sci
. 2021 Apr;
22(5).
PMID: 33807899
We aimed to evaluate the angiogenic capacity of CXCL2 and IL8 affecting human endothelial cells to clarify their potential role in glioblastoma (GBM) angiogenesis. Human GBM samples and controls were...